Stay informed with the latest litigation news. Explore now

IP Verse

Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies - EP3601363B1

EP3601363

ALTOR BIOSCIENCE
Application Number
EP18776459A
Filing Date
Mar 30, 2018
Status
Opposition Rejected
Oct 11, 2024
Grant Date
Jun 15, 2022
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3601363B1 was granted to Altor Bioscience on Jun 15, 2022 following the initial filing on Mar 30, 2018 under the application number EP18776459A . The current legal status of the patent is Opposition Rejected.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CYTUNE PHARMAMar 15, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents